PADI4 and systemic lupus erythematosus: One additional discrepancy between our data and published reports is the observation that PAD inhibitors (both selective and pan-PAD) show efficacy in multiple mouse models of SLE and RA (Knight et al., 2015; Ghari et al., 2016; Kawalkowska et al., 2016).